Omnicell (OMCL) Other Non Operating Income (2010 - 2015)
Omnicell's (OMCL) quarterly Other Non Operating Income came in at $3.4 million in Q2 2015, up 8707.5% year-over-year from $39091.7 in Q2 2014, and up 587.68% quarter-over-quarter from -$706000.0 in Q3 2014.
Analysis
Omnicell (OMCL) Other Non Operating Income (2010 - 2015) Analysis & Trends
Omnicell (OMCL) has reported Other Non Operating Income for 6 consecutive years, with $3.4 million the latest figure, recorded in Q2 2015.
- On a quarterly basis, Other Non Operating Income rose 8707.5% year-over-year to $3.4 million in Q2 2015; TTM through Sep 2016 was $3.4 million, a 27.66% increase from a year earlier, with the FY2013 full-year figure at -$270000.0, down 429.41% from the prior year.
- Other Non Operating Income was $3.4 million for Q2 2015 at Omnicell, up from -$706000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $3.4 million in Q2 2015 and troughed at -$706000.0 in Q3 2014.
- A 5-year average of $124125.0 and a median of -$53500.0 in 2011 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income tumbled 2924.0% in 2014 and jumped 8707.5% in 2015, its largest moves.
- Over 5 years, Other Non Operating Income stood at -$67000.0 in 2011, then plunged by 61.19% to -$108000.0 in 2012, then slipped by 25.93% to -$136000.0 in 2013, then slumped by 419.12% to -$706000.0 in 2014, then soared by 587.68% to $3.4 million in 2015.
- The last three Other Non Operating Income figures came in at $3.4 million (Q2 2015), -$706000.0 (Q3 2014), and -$40000.0 (Q2 2014), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 3.44 Mn |
| Sep 30, 2014 | -706,000.00 |
| Jun 30, 2014 | -40,000.00 |
| Mar 31, 2014 | -256,000.00 |
| Dec 31, 2013 | -136,000.00 |
| Sep 30, 2013 | 25,000.00 |
| Jun 30, 2013 | 63,000.00 |
| Mar 31, 2013 | -223,000.00 |
| Dec 31, 2012 | -108,000.00 |
| Sep 30, 2012 | 34,000.00 |
| Jun 30, 2012 | -73,000.00 |
| Mar 31, 2012 | 96,000.00 |
| Dec 31, 2011 | -67,000.00 |
| Sep 30, 2011 | -191,000.00 |
| Jun 30, 2011 | 71,000.00 |
| Mar 31, 2011 | 54,000.00 |
| Dec 31, 2010 | 145,000.00 |
| Sep 30, 2010 | 159,000.00 |
| Jun 30, 2010 | 53,000.00 |